DelveInsight sees point-of-care molecular diagnostics market reaching $14.8 billion by 2034
The GlobeNewswire-distributed report says the market was worth $6.2 billion in 2025, with North America holding about 46% of revenue and Asia-Pacific projected to grow fastest.